← FDA Drug Approvals (Drugs@FDA)

SYNJARDY

NDA · New Drug Application · Sponsor: BOEHRINGER INGELHEIM · Approved 2015-08-26

Drug application

FDA Application #

NDA206111

Application type

New Drug Application

Brand name

SYNJARDY

Generic name

EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE

Active ingredients

EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

BOEHRINGER INGELHEIM

Manufacturer

Boehringer Ingelheim Pharmaceuticals, Inc.

First approval

2015-08-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown